FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment

Kentaro Inoue, Ryoi Goto, Hideo Shimomura, Hiroshi Fukuda

Research output: Contribution to journalReview articlepeer-review

25 Citations (Scopus)

Abstract

Sarcoidosis or sarcoid reactions, which appear as FDG-avid lesions in oncologic patients, need to be differentiated from disseminated malignancies. We aimed to promote awareness of development of sarcoidosis or sarcoid reactions after antineoplastic therapy to avoid diagnostic errors with FDG-PET/CT findings and assess the utility of FDG-PET/CT for follow-up. We retrospectively reviewed radiological reports of FDG-PET/CT scans performed between January 2009 and December 2011. Among oncologic patients with more than 2 FDG-PET/CT scans, those with nearly symmetrical increases in FDG uptake in the hilar or mediastinal lymph nodes were identified, and those with known sarcoidosis, concurrent diagnoses of sarcoidosis with malignancy, or histopathologically proven malignancies were excluded. Then, only those cases were selected for which sarcoidosis or sarcoid reactions were diagnosed. Four of 376 oncologic cases met the criteria. At 9 months to 6 years after antineoplastic therapy, abnormal FDG uptakes were observed in the hilar, mediastinal, abdominal, pelvic, and inguinal nodes, and/or spleen and lung parenchyma with SUVmax up to 17.7. On the basis of these findings, 1 patient received anticancer chemotherapy because of tumor recurrence suspicion. A gradual decrease in FDG uptake was observed on subsequent PET/CT scans. Sarcoidosis or sarcoid reactions should be considered in differential diagnosis of oncologic patients who have developed FDG-avid lesions any time after antineoplastic therapy. FDG-PET/CT can be used for follow-up in nondiagnostic situations to detect decreases in FDG uptake due to presence of sarcoidal granulomas.

Original languageEnglish
Article number113
Pages (from-to)1-7
Number of pages7
JournalSpringerPlus
Volume2
Issue number1
DOIs
Publication statusPublished - 2013

Keywords

  • Cancer
  • FDG
  • Lymphadenopathy
  • Malignancy
  • PET
  • Sarcoid reactions
  • Sarcoidosis

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment'. Together they form a unique fingerprint.

Cite this